Thursday 24th April 2014 |
Text too small? |
Abano Healthcare Group is mulling the extraordinary general meeting request from rebel shareholders Peter Hutson and James Reeves who want to dump Trevor Janes as chairman and refresh the board.
In acknowledging the requisitioning of a special meeting by Hutson and Reeves, who together hold 19 percent of the company, the healthcare investor's board reiterated its support for Janes.
"The Abano board, which remains unanimous in its support for Mr Janes as chairman and in its support of the company's strategic direction, will now consider the requisition and update shareholders in due course," the company said in a statement.
The meeting would be preliminary to agree to an actual vote at another EGM on May 30 on whether to remove Janes as a director, giving Hutson's investment vehicle Healthcare Industry time to put its case in a statement to shareholders.
An EGM can be called at the request of 5 percent of a company's shareholders, which the pair's shareholdings easily exceed. They have nominated May 27 for the initial meeting.
The two investors say Abano's dental clinics are underperforming, providing an investment return of 3-4 percent a year since 2010 - less than banks are offering on deposit - and with more risk.
Abano shares were $6.50 before trading opened this morning, and have gained 2 percent this year.
BusinessDesk.co.nz
No comments yet
Hutson fails to respond to Abano buyout offer, takeover 'rife with insider elements'
Abano steps up pressure on bidders over audiology unit price
Abano shareholders clamour for discounted stock in share purchase plan
Hutson quits Abano board after urging from other directors
Abano board questions Hutson's conflict of interest in takeover bid
Abano continues to resist takeovers, rejects approach from Archer, Hutson
Abano seeks $18.5 mln in share purchase plan
Abano shares climb to 4-month high amid prospect of takeover bid
Abano faces takeover bid after rejecting unsolicited offer
Abano reports 75 percent NPAT uplift to $2.8 mln on $207 mln turnover